Whanin Pharm (016580) — Long-term Investment Intensity

Latest as of December 2019: 7.0%

Whanin Pharm (016580) has a Long-term Investment Intensity of 7.0% as of December 2019. Long-term investments of ₩21.21 Billion represent 7.0% of total assets of ₩304.88 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Whanin Pharm (016580) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

7.0%
LT Investments / Total Assets

Long-term Investments

₩21.21 Billion
KRW

Total Assets

₩304.88 Billion
KRW

Country

Korea
KO

Whanin Pharm Long-term Investment Intensity (2009–2019)

This chart shows how Whanin Pharm's Long-term Investment Intensity has evolved across 5 annual periods from 2009 to 2019. As of December 2019, the intensity stands at 7.0%, reflecting long-term investments of ₩21.21 Billion against total assets of ₩304.88 Billion KRW. For the complete balance sheet picture, see total assets of Whanin Pharm.

Annual Long-term Investment Intensity for Whanin Pharm (2009–2019)

The table below presents the year-by-year Long-term Investment Intensity for Whanin Pharm from 2009 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 016580 total debt and obligations for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 7.0% ₩21.21 Billion ₩304.88 Billion ▼ -0.6 pp
2018 7.5% ₩21.67 Billion ₩287.69 Billion ▲ +4.8 pp
2012 2.8% ₩5.00 Billion ₩181.43 Billion ▼ -0.3 pp
2011 3.0% ₩5.01 Billion ₩166.11 Billion ▲ +0.8 pp
2009 2.2% ₩2.59 Billion ₩118.95 Billion
pp = percentage points